Study suggests COVID-19 could be a potential trigger for ME/CFS.
Reports that a drug used to treat autoimmune diseases and cancer could also treat Chronic Fatigue Syndrome (CFS) have been refuted by a new Griffith study.
Inspiration, information and empowerment regarding the topic of Chronic Fatigue Syndrome is expected this week with the screening of movie documentary Unrest on the Gold Coast.
In a world first, Gold Coast researchers have made an important breakthrough in understanding the cause of Chronic Fatigue Syndrome.
A diagnostic test for Chronic Fatigue Syndrome could be available within five years following the awarding of $4 million in funding to one of Australia’s foremost authorities on the condition.
Chronic Fatigue Syndrome researchers have discovered a cell receptor which could be a key contributing factor to CFS, providing a much clearer picture of how to tackle the debilitating illness.
New findings regarding the pathology of Chronic Fatigue Syndrome (CFS) are bringing Griffith University researchers closer to identifying the cause of this disabling illness.